1. Zhou, Jiejun, Zhang, Kun, Yang, Tian, Peng, Xiaojing, Chen, Mingwei. 2024. Identification and validation of a glycosyltransferase gene signature as a novel prognostic model for lung adenocarcinoma. In Heliyon, 10, e29383. doi:10.1016/j.heliyon.2024.e29383. https://pubmed.ncbi.nlm.nih.gov/38644835/
2. MacKenzie, Peter I, Rogers, Anne, Elliot, David J, Miners, John O, Meech, Robyn. 2010. The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution. In Molecular pharmacology, 79, 472-8. doi:10.1124/mol.110.069336. https://pubmed.ncbi.nlm.nih.gov/21088224/
3. Wang, Cong, Chen, Fang, Liu, Yichen, He, Lin, Qin, Shengying. 2018. Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients. In Frontiers in pharmacology, 9, 360. doi:10.3389/fphar.2018.00360. https://pubmed.ncbi.nlm.nih.gov/29695969/
4. Lu, Hong, Gonzalez, Frank J, Klaassen, Curtis. 2010. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. In Toxicological sciences : an official journal of the Society of Toxicology, 118, 380-90. doi:10.1093/toxsci/kfq280. https://pubmed.ncbi.nlm.nih.gov/20935164/
智鼠故事 
